+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Combination Vaccine & Multivalent Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134376
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Veterinary combination and multivalent vaccines are rapidly transforming approaches to animal health management, enabling comprehensive disease prevention through consolidated immunization strategies tailored to diverse industry needs.

Market Snapshot: Veterinary Combination and Multivalent Vaccines

The veterinary vaccine market is experiencing a significant evolution, with combination and multivalent vaccines now prioritized for their role in streamlining immunization, reducing animal stress, simplifying logistics, and supporting robust animal welfare. The ongoing shift from monovalent to combination vaccines reflects industry-wide demand for operational efficiency alongside broad-spectrum protection across aquatic environments, livestock operations, equine settings, companion animals, and wildlife programs.

Scope & Segmentation of the Market

This report delivers in-depth analysis of combination and multivalent veterinary vaccine opportunities, incorporating comprehensive coverage by segment, geography, and technology:

  • Animal Types: Includes aquatic species (fish), companion animals (cats, dogs), equine (horses), livestock (cattle, poultry, sheep/goats, swine), and wildlife (deer, furbearers).
  • Product Types: Covers conjugate vaccines, inactivated vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines.
  • Routes of Administration: Evaluates market relevance for intramuscular, intranasal, oral, and subcutaneous delivery methods.
  • End Users: Focuses on animal farms (cattle, poultry, swine), research institutes, and veterinary hospitals & clinics.
  • Distribution Channels: Assesses direct sales, distribution networks, and online platforms.
  • Geographies: Analyzes Americas (United States & leading states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key EU and regional markets), and Asia-Pacific (China, India, Japan, Australia, Southeast Asia).
  • Key Industry Players: Reviews activities by Zoetis, Merck & Co., Elanco, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Vetoquinol, HIPRA, Bimeda, and IDT Biologika.
  • Technological Innovations: Highlights advances in recombinant antigen platforms, adjuvant systems, nucleic-acid vaccines, vector-based deliveries, and digital cold chain technologies.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Combination and multivalent vaccines minimize herd handling frequency, lowering both animal stress and operational costs, while broadening immunological protection.
  • Market adoption is driven by tailored immunization regimens: oral and immersion vaccines for aquaculture, and intranasal approaches for respiratory pathogens in livestock and companion animals.
  • Major advances in recombinant and vector-based vaccine technology enable expanded antigen pairing without sacrificing safety or efficacy.
  • Regulatory harmonization and digital monitoring solutions are compressing time to market, while supporting supply chain resilience and traceability.
  • Disease management strategies now emphasize collaboration by integrating veterinarians, producers, and research institutions across all regional markets and segments.
  • The emergence of online distribution channels supports streamlined ordering for smaller-scale end users, increasing market access and efficiency.

Tariff Impact: Navigating US Policy Adjustments

Recent 2025 adjustments to United States tariff schedules have increased costs on key vaccine inputs, including antigen substrates, adjuvants, and packaging. Manufacturers are mitigating impacts by expanding domestic capacity, diversifying suppliers through alternative sourcing in tariff-exempt regions, and restructuring partnerships with CDMOs. Distributors respond by focusing on higher-margin products and optimizing direct sales. These developments are accelerating innovation in thermostable vaccine formulations and advanced delivery systems, supporting long-term market resiliency.

Methodology & Data Sources

The report applies a multi-layered research approach, integrating primary interviews with industry and academic experts, structured stakeholder surveys, and robust secondary analysis from scientific literature, regulatory guidance, and authoritative market databases. Triangulation and expert workshops ensure findings reflect real-world practices and opportunities.

Why This Report Matters

  • Enables leaders to align portfolio development with market-ready technologies and regional regulatory frameworks.
  • Supports proactive risk and cost management in the face of policy shifts, supply chain constraints, and evolving buyer preferences.
  • Equips stakeholders with actionable insights on partnership strategies and channel optimization to maximize operational efficiency.

Conclusion

Veterinary combination and multivalent vaccines are reshaping animal health management by delivering comprehensive protection across key species and settings. The outlook is defined by technological innovation, collaborative partnerships, and responsive supply chain strategies that support sustainable long-term growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of recombinant vector technologies enabling broader multivalent protection in companion animal vaccines
5.2. Rising investment in mRNA and DNA platforms to develop rapid-response veterinary multivalent vaccines for livestock
5.3. Integration of broad-spectrum antigens to cover multiple foot-and-mouth disease serotypes in cattle vaccine portfolios
5.4. Growing emphasis on temperature-stable formulations to facilitate cold-chain independent distribution in remote veterinary markets
5.5. Regulatory harmonization initiatives across North America, Europe, and Asia to streamline multivalent vaccine approvals for pets
5.6. Automated and needle-free vaccine delivery systems reshaping high-volume poultry combination immunization protocols
5.7. Emerging demand for combination respiratory vaccines in poultry to improve flock health and reduce administration labor
5.8. Strategic partnerships between biotech firms and contract manufacturers accelerating multivalent vaccine scale-up for livestock
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Animal Type
8.1. Introduction
8.2. Aquatic
8.2.1. Fish
8.3. Companion Animals
8.3.1. Cats
8.3.2. Dogs
8.4. Equine
8.4.1. Horses
8.5. Livestock
8.5.1. Cattle
8.5.2. Poultry
8.5.3. Sheep & Goat
8.5.4. Swine
8.6. Wildlife
8.6.1. Deer
8.6.2. Furbearers
9. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Product Type
9.1. Introduction
9.2. Conjugate Vaccine
9.3. Inactivated Vaccine
9.4. Live Attenuated Vaccine
9.5. Recombinant Vaccine
9.6. Toxoid Vaccine
10. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Route Of Administration
10.1. Introduction
10.2. Intramuscular
10.3. Intranasal
10.4. Oral
10.5. Subcutaneous
11. Veterinary Combination Vaccine & Multivalent Vaccine Market, by End User
11.1. Introduction
11.2. Animal Farms
11.2.1. Cattle Farms
11.2.2. Poultry Farms
11.2.3. Swine Farms
11.3. Research Institutes
11.4. Veterinary Hospitals & Clinics
12. Veterinary Combination Vaccine & Multivalent Vaccine Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Americas Veterinary Combination Vaccine & Multivalent Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Veterinary Combination Vaccine & Multivalent Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Veterinary Combination Vaccine & Multivalent Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Merck & Co., Inc.
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Ceva Santé Animale
16.3.5. Elanco Animal Health Incorporated
16.3.6. Virbac S.A.
16.3.7. Vetoquinol S.A.
16.3.8. HIPRA, S.L.
16.3.9. Bimeda, Inc.
16.3.10. IDT Biologika GmbH
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET: RESEARCHAI
FIGURE 26. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY HORSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SHEEP & GOAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SHEEP & GOAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DEER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DEER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY FURBEARERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY FURBEARERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATTLE FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY CATTLE FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY POULTRY FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY POULTRY FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SWINE FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY SWINE FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 148. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 149. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 150. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 151. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 152. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 153. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 154. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 155. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 156. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 157. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 164. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 165. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. CANADA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 170. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 171. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 176. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 177. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. MEXICO VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY AQUATIC, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY EQUINE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY WILDLIFE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY ANIMAL FARMS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA VETERINARY COMBINATION VACCINE & MULTIVALENT VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Veterinary Combination Vaccine & Multivalent Vaccine Market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.L.
  • Bimeda, Inc.
  • IDT Biologika GmbH